“Study Design to Examine the Potential Role of Assessment Reactivity in Screening, Motivational Assessment, Referral and Treatment in Emergency Departments (SMART-ED) Protocol”, Addict Sci Clin Pract, vol. 7, p. 16, 2012.
, , , “Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo Controlled Multicenter Trial”, J Allergy Clin Immunol, vol. 131, pp. 119-127.e1-7, 2013.
, “Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial.”, J Allergy Clin Immunol, vol. 131, no. 1, pp. 119-27.e1-7, 2013.
, “Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial.”, J Allergy Clin Immunol, vol. 135, no. 5, pp. 1240-8.e1-3, 2015.
, “Sublingual Immunotherapy for Peanut Allergy: Long-Term Follow-up of a Randomized Multicenter Trial”, J Allergy Clin Immunol, 2015.
, “Substance Abuse Increases the Risk of Neuropathy in an HIV-Infected Cohort”, Muscle & Nerve, vol. 45, pp. 471-476, 2012.
, “Substance abuse increases the risk of neuropathy in an HIV-infected cohort.”, Muscle Nerve, vol. 45, no. 4, pp. 471-6, 2012.
, “Substance-use screening and interventions in dental practices: survey of practice-based research network dentists regarding current practices, policies and barriers.”, J Am Dent Assoc, vol. 144, no. 6, pp. 627-38, 2013.
, “Substance-Use Screening and Interventions in Dental Practices: Survey of Practice-Based Research Network Dentists Regarding Current Practices, Policies and Barriers”, J Am Dent Assoc, vol. 144, pp. 627-638, 2013.
, , “A Successful Support Program for Cell Therapy: An Update from the Production Assistance for Cellular Therapies (PACT) Group”, Transfusion, vol. 53, p. Supplement AP34, 2013.
, “Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder Cancer.”, Bladder Cancer, vol. 2, no. 2, pp. 165-202, 2016.
, “Summary results and recommendations from the age-related eye disease study.”, Arch Ophthalmol, vol. 127, no. 12, pp. 1678-9, 2009.
, “Summary Results and Recommendations from the Age-Related Eye Disease Study”, Arch Ophthalmol, vol. 127, pp. 1678-1679, 2009.
, “Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.”, Pediatrics, vol. 105, no. 2, pp. 295-310, 2000.
“Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized controlled trial 1: Primary outcomes”, Pediatrics, vol. 105, pp. 295-310, 2000.
, “Surgical Complications in 275 HIV-Infected Liver and/or Kidney Transplantation Recipients”, Surgery, vol. 152, pp. 376-381, 2012.
, “Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients.”, Surgery, vol. 152, no. 3, pp. 376-81, 2012.
, “A survey of the NIH CAPD Registry population with end-stage renal disease attributed to diabetic nephropathy.”, J Diabet Complications, vol. 2, no. 4, pp. 227-32, 1988.
, “Survival after postoperative combination treatment of rectal cancer.”, N Engl J Med, vol. 315, no. 20, pp. 1294-5, 1986.
, “Survival analysis of drug combinations using a hazards model with time-dependent covariates.”, Biometrics, vol. 36, no. 3, pp. 537-46, 1980.
, “Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls.”, AIDS, vol. 30, no. 3, pp. 435-44, 2016.
, “Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy.”, Eye (Lond), vol. 23, no. 1, pp. 209-14, 2009.
,